Education Hub

ARRS roles are typically employed or hosted by a PCN (or a member practice, or a trusted third party such as Oea Healthcare) and reimbursed against nationally agreed reimbursement rules. For PCNs, this means clinical pharmacist capacity can often be added without competing against core practice staffing budgets. Getting the most from an ARRS pharmacist role usually comes down to three things: clear role scoping from day one, proper clinical supervision, and integrating the role into existing practice workflows rather than treating it as an add-on. We help PCNs work through all three as part of onboarding any placement.

Unlike a quick repeat-prescription check, an SMR looks at whether each medicine is still needed, still working, still safe, and still wanted by the patient. It considers interactions, adherence, and whether simpler or safer alternatives exist. Because SMRs take time - often 20-30 minutes per patient for complex cases - many practices find dedicated clinical pharmacist capacity is the only realistic way to deliver them at scale without displacing GP appointments.

Effective care home medication reviews go beyond the drug chart - they involve conversations with care staff about how a resident is actually managing day to day, cross-checking MAR charts against current prescriptions, and looking for medicines that may no longer align with the resident's goals of care. Regular, scheduled reviews (rather than one-off audits) tend to produce the most durable improvements in safety and appropriateness of prescribing.

Because pharmacists are often the clinician with the clearest view of a patient's full medicines list, they're well placed to close gaps in QOF-related medication reviews, ensure accurate coding, and flag patients who need clinical follow-up. This work is most effective when built into a practice's existing QOF workflow rather than run as a separate parallel process.

A safe deprescribing approach typically starts by identifying the highest-risk or lowest-benefit medicines, agreeing a plan with the patient (and family or carers where relevant), then reducing doses gradually with clear monitoring points. Shared decision-making is central - deprescribing should never feel like something being done to a patient, but a conversation about what matters to them.

Common presentations suited to pharmacist-led triage include self-limiting infections, minor skin conditions, and straightforward long-term condition queries. The key to making this work well is a clear, agreed protocol for escalation - so patients who need a GP or urgent care are identified quickly, and pharmacists work within a well-defined clinical scope.